Gain Therapeutics Awarded CHF 2 5 million Innosuisse Grant to Advance Lead Program in GBA1 Parkinson s Disease streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Gain Therapeutics (NASDAQ:GANX – Get Rating) and Flora Growth (NASDAQ:FLGC – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, analyst recommendations, profitability and institutional ownership. Valuation & Earnings This table compares Gain Therapeutics and […]
Gain Therapeutics, Inc. (NASDAQ:GANX – Get Rating) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 60,000 shares, a growth of 20.2% from the March 15th total of 49,900 shares. Approximately 0.7% of the shares of the company are short sold. Based on […]
Should You Buy or Sell Gain Therapeutics Stock? Get The Latest GANX Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.